ϟ
 
DOI: 10.1056/nejmoa1412168
¤ OpenAccess: Bronze
This work has “Bronze” OA status. This means it is free to read on the publisher landing page, but without any identifiable license.

Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Disease

Sripal Bangalore,Yu Guo,Zaza Samadashvili,Saul Blecker,Jinfeng Xu,Edward L. Hannan

Medicine
Everolimus
Coronary disease
2015
Results of trials and registry studies have shown lower long-term mortality after coronary-artery bypass grafting (CABG) than after percutaneous coronary intervention (PCI) among patients with multivessel disease. These previous analyses did not evaluate PCI with second-generation drug-eluting stents.
Loading...
    Cite this:
Generate Citation
Powered by Citationsy*
    Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Disease” is a paper by Sripal Bangalore Yu Guo Zaza Samadashvili Saul Blecker Jinfeng Xu Edward L. Hannan published in 2015. It has an Open Access status of “bronze”. You can read and download a PDF Full Text of this paper here.